文献速递炎症性肠病消化内镜

利用现有中端超声设备在低资源环境下开展床旁肠道超声:对临床决策的前瞻性真实世界影响

Leveraging existing mid-end ultrasound machine for point-of-care intestinal ultrasound in low-resource settings: Prospective, real-world impact on clinical decision-making.
PubMed 文献 · Aliment Pharmacol Ther · 2024-07-08

前瞻性评估利用现有中端超声设备、不额外增加成本的床旁超声(POCUS)对炎症性肠病(IBD)临床决策的影响。共分析419例IBD患者的556次POCUS检查,POCUS联合或不联合粪便钙卫蛋白独立影响42.8%的克罗恩病(CD)和49.7%的溃疡性结肠炎(UC)患者的临床管理,并帮助51.4%的CD和51.8%的UC患者避免结肠镜检查。

要点

  • POCUS联合或不联合FCP独立影响42.8%CD和49.7%UC患者的临床管理。
  • POCUS帮助51.4%CD和51.8%UC患者避免结肠镜检查,38.1%疑似活动性小肠CD避免横断面成像。
  • 与回结肠镜相比,POCUS对CD的敏感度80%、特异度94.4%,对UC分别为80.8%和92.8%。

核心结论

  • 在低资源环境下利用现有中端超声设备开展POCUS可影响IBD临床决策且准确性优异,常可避免结肠镜和横断面成像。

研究设计与样本

  • 前瞻性研究,连续纳入IBD患者,使用中端超声设备行POCUS联合或不联合粪便钙卫蛋白(FCP)。
  • 若POCUS联合或不联合FCP无法指导管理,则追加回结肠镜或横断面成像。
  • 共分析419例IBD患者(60.4%为克罗恩病,61.3%为男性,年龄36岁[18-78])的556次POCUS检查。
  • 另单独分析妊娠、儿童和术后患者。

主要发现

  • POCUS联合或不联合FCP独立影响42.8%CD患者和49.7%UC患者的临床管理。
  • POCUS帮助51.4%CD患者和51.8%UC患者避免结肠镜检查,帮助38.1%疑似活动性小肠CD患者避免横断面成像。
  • 在追加诊断检查的患者中,基于POCUS的决策在81.2%CD患者和85%UC患者中保持不变。
  • 与回结肠镜相比,POCUS对CD的敏感度和特异度分别为80%和94.4%,对UC分别为80.8%和92.8%。
  • 与横断面成像相比,POCUS的敏感度和特异度分别为87.2%和87.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Point-of-care ultrasound (POCUS) has transformed inflammatory bowel disease (IBD) management, but the cost to purchase high-end equipment can be prohibitive. AIM: To assess prospectively the feasibility of POCUS using pre-existing mid-end ultrasound equipment without incurring additional cost. METHODS: Consecutive IBD patients underwent POCUS with or without faecal calprotectin (FCP) using a mid-end ultrasound machine. If POCUS with or without FCP could not guide management, we performed additional ileocolonoscopy or cross-sectional imaging. We evaluated the impact of POCUS on IBD management and its correlation with ileocolonoscopy or cross-sectional imaging. We analysed pregnant, paediatric and post-operative patients separately. RESULTS: Among 508 patients with IBD, we analysed 419 (60.4% Crohn's disease [CD]; 61.3% male, age [years]: 36 [18-78]) undergoing 556 POCUS sessions. POCUS with or without FCP independently influenced clinical management in 42.8% of patients with CD and 49.7% with ulcerative colitis (UC). POCUS helped avoid colonoscopy in 51.4% of patients with CD and 51.8% with UC, and cross-sectional imaging in 38.1% of suspected active small bowel CD. In patients with additional diagnostics, POCUS-based decisions remained unchanged in 81.2% with CD and 85% with UC. Sensitivity and specificity of POCUS compared to ileocolonoscopy were 80% and 94.4% for CD and 80.8% and 92.8% for UC, respectively. Sensitivity and specificity compared to cross-sectional imaging were 87.2% and 87.5%, respectively. CONCLUSION: POCUS using existing mid-end ultrasound equipment in low-resource settings influenced IBD clinical decision-making with excellent accuracy, often avoiding colonoscopy and cross-sectional imaging.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Pal P, Mateen MA, Pooja K, et al. Leveraging existing mid-end ultrasound machine for point-of-care intestinal ultrasound in low-resource settings: Prospective, real-world impact on clinical decision-making. Aliment Pharmacol Ther. 2024. PMID: 38975815. doi:10.1111/apt.18155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。